Company intelligence / Profile preview

Encapsulate

Farmington, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Encapsulate is conducting clinical studies for pancreatic and colorectal cancers with 100-200 patients planned across multiple sites including UConn Health, Moffitt Cancer Center, and Memorial Sloan Kettering Cancer Center. Earlier blind trials on archived samples showed over 96% predictability in matching clinical reality. The company has successfully tested its technology on six patients in space.

Therapeutic areas: Oncology
Industry: Pathology

Partnerships

Space TangoBoeingInternational Space Station National LaboratoryNASAUConn HealthMoffitt Cancer CenterMemorial Sloan Kettering Cancer CenterHartford Hospital

Beyond the preview

Go deeper on Encapsulate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Encapsulate.

Explore the full profile